WHITE OAK, Md., U.S./GOTHENBURG, Sweden: Osstell, the developer of the proprietary diagnostic technology Osstell ISQ (Implant Stability Quotient), has announced that the Osstell Beacon is now available in the U.S. after receiving clearance from the Food and Drug Administration. The Osstell Beacon is a new, innovative and highly intuitive tool designed to assess dental implant stability.
Patients—the priority for Osstell and its users—are increasingly well informed before seeking implant treatment and are often aware of available treatment options. They are increasingly expecting shorter treatment protocols. In addition, there is a growing aging and medically compromised patient population for whom healing, for many reasons, can be unpredictable. In order to meet these demands and changing demographics, there is a need for innovative diagnostic tools to help the individual clinician deliver these treatment protocols while ensuring predictability and patient satisfaction. The more than 1,000 studies where Osstell ISQ technology has been used provide evidence that Osstell ISQ diagnostics can help improve outcomes and quality by using objective data to guide and optimize the implant treatment for both complex and more straightforward cases.
Optimize restorative protocol
The Osstell ISQ technology can assist when determining the patient-specific restorative protocol. It can help the clinician to decide when each implant of an individual patient is ready to be restored, both with temporary solutions as well as with the final restoration.
Ease of use
The Osstell Beacon makes the stability measurement very intuitive. The Osstell ISQ measurements are presented also with a colored indication on the instrument, as a result of the clinical evidence gained from using the Osstell ISQ scale. This gives a visual aid of the implant stability status.
Osstell’s Vice President of Product Development Stefan Horn said, “We have listened to our users who need easy to use and intuitive tools to assess implant stability. Accordingly, we have developed a complement to the more comprehensive Osstell IDx to meet the needs from all clinicians, from small private practices to large university clinics. Although very advanced on the inside, we believe that the Osstell Beacon will be appreciated for its ease of use and making the stability measurement very intuitive.”
Osstell is currently also focusing on developing a new concept combining the best of the Osstell Beacon and the current Osstell IDx. This concept, called Osstell IDx Pro, will allow the user to take a measurement with the wireless, smart and very intuitive Osstell Beacon and visualize implant stability development on the large display and comprehensive user interface of the Osstell IDx, combined with patient data storage and full connectivity.
“Osstell’s innovative and patented technology helps dentists around the world to make dental implant treatments more predictable, thereby helping clinicians improve patient confidence and comfort. We always aim to serve our customers and users with ever better products and services as well as help them to provide best practice services to their customers—the patients. Patients’ well-being is always the top priority. With this—the Osstell Beacon—being the newest addition, we take another important major step towards making our technology, products and approach even more accessible,” said Jonas Ehinger, CEO of Osstell.
Tags:
Osstell, developer of the proprietary diagnostic technology Osstell ISQ (Implant Stability Quotient), has announced that the Osstell Beacon is now available...
NEW YORK, USA/LEIPZIG, Germany: Dentists in the USA now have access to the new OsseoSpeed TX line from Astra Tech. The Sweden-based manufacturer launched ...
HOUSTON, Texas, USA: Forward Science Technologies LLC (FST) has announced that OralID will be available in Europe for sale this fall. The company acquired ...
JUPITER, Fla., USA: Southern Implants North America (SINA) has received FDA 510(k) clearance for its innovative internal hex dental implant system, PROVATA,...
Street Smart Investing is a Vancouver-based company that was established in April 2008. The company principals, Larry McGuinness and Jackie Speth, have 20 ...
Despite recovering from a formally recessed U.S. market, many patients continue to opt away from expensive, elective dental procedures. The market for ...
In October, the Swiss dental company vVARDIS hosted a symposium to introduce dental professionals to the paradigm-shifting technology of Curodont, a ...
CLEVELAND, US: The menopause is marked by alterations in reproductive hormone levels, and this can have adverse effects on bone health. Since chronic kidney...
NEWARK, New Jersey, US: The specialty of orofacial pain (OFP) has been officially recognised by the American Dental Association (ADA) for over four years. ...
It’s an interesting paradox of these economic times. Although the unemployment rate nationwide remains high and it would seem that the job market ...
Live webinar
Thu. 18 July 2024
8:00 PM EST (New York)
Live webinar
Tue. 6 August 2024
6:00 PM EST (New York)
Live webinar
Tue. 13 August 2024
7:00 PM EST (New York)
Live webinar
Wed. 14 August 2024
12:30 PM EST (New York)
Live webinar
Wed. 21 August 2024
9:00 AM EST (New York)
Dr. Jim Lai DMD, MSc(Perio), EdD, FRCD(C)
Live webinar
Wed. 28 August 2024
8:00 PM EST (New York)
Live webinar
Mon. 2 September 2024
5:00 AM EST (New York)
To post a reply please login or register